Delivery Order SPE2DB24D1201-SPE2DB25FJBVK

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $22K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $42,839.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, with a completion date of December 10, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside used. Amerisourcebergen Drug Corp is the prime contractor, and...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a Delivery Order under the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,688.62, is for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of July 10, 2024. This award is not designated with a set-aside requirement, indicating open competition....
The federal contract award is to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of JARDIANCE 10 MG TABLET 90S. The contract, valued at $5,871.96, is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of February 11, 2025 and utilizes a firm fixed-price pricing type. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award, valued at $5,439.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, with a completion date of January 7, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $47,827.23, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a prescription medication. This contract award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has an award ceiling value of $5,601.21 and an ultimate completion date of December 23, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
This federal contract award, valued at $10,432.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567075332 JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a final completion date of January 29, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open...
This federal contract award, valued at $15,421.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and covers the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract has an Ultimate Completion Date of November 19, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, with ID SPE2DB20D2001|SPE2DB25FPLLF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $40,134.73, is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 12, 2024. This contract award is associated with a larger Indefinite Delivery...
This federal contract award, with ID SPE2DB20D2014|SPE2DB25FA27Q, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $31,056.59 firm fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of November 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB25FJBVK
    Delivery Order

The federal contract award, with ID SPE2DB24D1201|SPE2DB25FJBVK, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, has a ceiling value of $21,643.03 and an ultimate completion date of March 11, 2025. The contract is for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and there are no major subcontractors mentioned. The DLA, which is a Defense agency, is the funding agency for this contract. This contract award is likely part of the company's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/9/25, 9:52 AM